Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Newly developed oral bioavailable EHMT2 inhibitor as a po... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome
0
Authors
Sung Wang
8 more
Sung Wang
•
Yan Xiong
6 more
•
Yong‐Hui Jiang
Published
May 24, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Molecular Therapy
Topics
Biology
Bioinformatics
Genetics
Molecular Biology
Candidate Gene
Show all topics
DOI
10.1016/j.ymthe.2024.05.034
